{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:27:54Z","timestamp":1784298474071,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Council of the Capital Region of Denmark"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0027594"],"award-info":[{"award-number":["NNF17OC0027594"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0027594"],"award-info":[{"award-number":["NNF17OC0027594"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF14CC0001"],"award-info":[{"award-number":["NNF14CC0001"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20SA0064340"],"award-info":[{"award-number":["NNF20SA0064340"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["grant number PPRPGM-Nov20\\100002"],"award-info":[{"award-number":["grant number PPRPGM-Nov20\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer risk prediction approaches clinical practice. The BOADICEA risk model has been updated to consider common breast cancer risk variants, lifestyle\/hormonal risk factors and mammographic density (MD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>49,494 women from the Danish Blood Donor Study were followed for up to 10 years. Modified BOADICEA risks within 5 and 10 years were calculated based on a polygenic breast cancer risk score combined with lifestyle\/hormonal risk factors. MD was only known for 4608 women. Calibration was assessed by comparing observed and predicted risks. AUC and Harrell\u2019s concordance index (C-index) were used to assess discriminative ability and sensitivities and specificities were obtained for high and low-risk groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within 5 and 10 years, 367 and 617 women had breast cancer. The 5-year model achieved an AUC of 0.80 (95% CI:0.78\u20130.81), sensitivity of 0.34 and specificity of 0.92 for all and an AUC of 0.61 (95% CI:0.58\u20130.65) for the 50-69-year-aged. For this age-group, the sensitivity was 0.46 in the 10-year model. 50% of women with the highest 5-year risk predictions, identified 94.8% of those with incident breast cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The modified BOADICEA risk model provided valid risks among a large retrospective cohort of Danish women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03247-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:28:56Z","timestamp":1762921736000},"page":"259-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breast cancer risk prediction with a modified BOADICEA model in Danish women"],"prefix":"10.1038","volume":"134","author":[{"given":"Sif Ingibergsd\u00f3ttir","family":"Novitski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Louise","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"R\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Christoffer","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-369X","authenticated-orcid":false,"given":"Michael","family":"Schwinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-203X","authenticated-orcid":false,"given":"Ilse","family":"Vejborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My Catarina","family":"von Euler-Chelpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-3851","authenticated-orcid":false,"given":"Sisse R.","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-9077","authenticated-orcid":false,"given":"Erik","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-5976","authenticated-orcid":false,"given":"Ole Birger","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Erikstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8306-1332","authenticated-orcid":false,"given":"Bitten","family":"Aagaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-6798","authenticated-orcid":false,"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DBDS Genomic Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Birger","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Erikstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitten Aagaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00f3runn","family":"Rafnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Brunak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00f3runn","family":"Rafnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Mavaddat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-1571","authenticated-orcid":false,"given":"Lorenzo","family":"Ficorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-5866","authenticated-orcid":false,"given":"S\u00f8ren","family":"Brunak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-4133","authenticated-orcid":false,"given":"Stig Egil","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"3247_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3247_CR2","unstructured":"Lar\u00f8nningen S, Ferlay J, Beydogan H, Bray F, Engholm G, Ervik M, et al. (2022). NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 9.2 (23.06.2022). Association of the Nordic Cancer Registries. [cited 2023 Sep 8]. Available from: https:\/\/nordcan.iarc.fr\/"},{"key":"3247_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000503219","volume":"14","author":"U Dafni","year":"2019","unstructured":"Dafni U, Tsourti Z, Alatsathianos I. Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries. Breast Care. 2019;14:344\u201353.","journal-title":"Breast Care"},{"key":"3247_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1634\/theoncologist.8-4-326","volume":"8","author":"A McTiernan","year":"2003","unstructured":"McTiernan A. Behavioral risk factors in breast cancer: can risk be modified?. Oncologist. 2003;8:326\u201334.","journal-title":"Oncologist"},{"key":"3247_CR5","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:1674.","journal-title":"Ann Oncol"},{"key":"3247_CR6","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA"},{"key":"3247_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. N Engl J Med. 2021;384:428\u201339.","journal-title":"N Engl J Med"},{"key":"3247_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104:21\u201334.","journal-title":"Am J Hum Genet"},{"key":"3247_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0140-6736(93)91067-V","volume":"341","author":"L Nystr\u00f6m","year":"1993","unstructured":"Nystr\u00f6m L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryd\u00e9n S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993;341:973\u20138.","journal-title":"Lancet"},{"key":"3247_CR10","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205\u201340.","journal-title":"Br J Cancer"},{"key":"3247_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ijc.30758","volume":"141","author":"A-B Beau","year":"2017","unstructured":"Beau A-B, Lynge E, Njor SH, Vejborg I, Lophaven SN. Benefit-to-harm ratio of the Danish breast cancer screening programme. Int J Cancer. 2017;141:512\u20138.","journal-title":"Int J Cancer"},{"key":"3247_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bmj.38313.639236.82","volume":"330","author":"AH Olsen","year":"2005","unstructured":"Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330:220.","journal-title":"BMJ"},{"key":"3247_CR13","doi-asserted-by":"publisher","first-page":"e222440","DOI":"10.1001\/jamanetworkopen.2022.2440","volume":"5","author":"T-QH Ho","year":"2022","unstructured":"Ho T-QH, Bissell MCS, Kerlikowske K, Hubbard RA, Sprague BL, Lee CI, et al. Cumulative probability of false-positive results after 10 years of screening with digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2022;5:e222440.","journal-title":"JAMA Netw Open"},{"key":"3247_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3929-6","volume":"17","author":"E Lynge","year":"2017","unstructured":"Lynge E, Bak M, von Euler-Chelpin M, Kroman N, Lernevall A, Mogensen NB, et al. Outcome of breast cancer screening in Denmark. BMC Cancer. 2017;17:897.","journal-title":"BMC Cancer"},{"key":"3247_CR15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ijc.33602","volume":"149","author":"J-L Bulliard","year":"2021","unstructured":"Bulliard J-L, Beau A-B, Njor S, Wu WY-Y, Procopio P, Nickson C, et al. Breast cancer screening and overdiagnosis. Int J Cancer. 2021;149:846\u201353.","journal-title":"Int J Cancer"},{"key":"3247_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1470-2045(07)70380-7","volume":"8","author":"C Biesheuvel","year":"2007","unstructured":"Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol. 2007;8:1129\u201338.","journal-title":"Lancet Oncol"},{"key":"3247_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10549-020-05896-9","volume":"184","author":"E Lynge","year":"2020","unstructured":"Lynge E, Beau A-B, von Euler-Chelpin M, Napolitano G, Njor S, Olsen AH, et al. Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark. Breast Cancer Res Treat. 2020;184:891\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"3247_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41416-019-0524-4","volume":"121","author":"H Long","year":"2019","unstructured":"Long H, Brooks JM, Harvie M, Maxwell A, French DP. How do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studies. Br J Cancer. 2019;121:351\u20138.","journal-title":"Br J Cancer"},{"key":"3247_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23:1111\u201330.","journal-title":"Stat Med"},{"key":"3247_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21:1708\u201318.","journal-title":"Genet Med"},{"key":"3247_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","volume":"17","author":"N Pashayan","year":"2020","unstructured":"Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020;17:687\u2013705.","journal-title":"Nat Rev Clin Oncol"},{"key":"3247_CR22","doi-asserted-by":"publisher","unstructured":"Erikstrup C, S\u00f8rensen E, Nielsen KR, Bruun MT, Petersen MS, Rostgaard K, et al. Cohort Profile: The Danish Blood Donor Study. Int J Epidemiol. 2022 Oct 4; Available from: https:\/\/doi.org\/10.1093\/ije\/dyac194","DOI":"10.1093\/ije\/dyac194"},{"key":"3247_CR23","doi-asserted-by":"publisher","first-page":"e028401","DOI":"10.1136\/bmjopen-2018-028401","volume":"9","author":"TF Hansen","year":"2019","unstructured":"Hansen TF, Banasik K, Erikstrup C, Pedersen OB, Westergaard D, Chmura PJ, et al. DBDS Genomic Cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors. BMJ Open. 2019;9:e028401.","journal-title":"BMJ Open"},{"key":"3247_CR24","unstructured":"Screeningsrunde -. 7. Dansk Kvalitetsdatabase for Mammografiscreening [Internet]. [cited 2025 Feb 6]. Available from: https:\/\/www.sundk.dk\/media\/m5an0hrc\/dkms-aarsrapport-2024.pdf"},{"key":"3247_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12863-023-01132-7","volume":"24","author":"K Banasik","year":"2023","unstructured":"Banasik K, M\u00f8ller PL, Techlo TR, Holm PC, Walters GB, Ingason A, et al. DanMAC5: a browser of aggregated sequence variants from 8,671 whole genome sequenced Danish individuals. BMC Genom Data. 2023;24:30.","journal-title":"BMC Genom Data"},{"key":"3247_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/1055-9965.EPI-22-0756","volume":"32","author":"N Mavaddat","year":"2023","unstructured":"Mavaddat N, Ficorella L, Carver T, Lee A, Cunningham AP, Lush M, et al. Incorporating alternative polygenic risk scores into the BOADICEA breast cancer risk prediction model. Cancer Epidemiol Biomark Prev. 2023;32:422\u20137.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3247_CR27","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44:535\u20139.","journal-title":"Dan Med Bull"},{"key":"3247_CR28","first-page":"445","volume":"44","author":"D Gaist","year":"1997","unstructured":"Gaist D, S\u00f8rensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44:445\u20138.","journal-title":"Dan Med Bull"},{"key":"3247_CR29","doi-asserted-by":"publisher","first-page":"e51580","DOI":"10.1371\/journal.pone.0051580","volume":"7","author":"D-M Bretler","year":"2012","unstructured":"Bretler D-M, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Jensen TB, et al. Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction-a nationwide cohort study. PLoS One. 2012;7:e51580.","journal-title":"PLoS One"},{"key":"3247_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canep.2017.05.006","volume":"49","author":"RR Winkel","year":"2017","unstructured":"Winkel RR, Euler-Chelpin M, von, Lynge E, Diao P, Lillholm M, Kallenberg M, et al. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study. Cancer Epidemiol. 2017;49:53\u201360.","journal-title":"Cancer Epidemiol"},{"key":"3247_CR31","unstructured":"American College of Radiology BI-RADS Committee. ACR BI-RADS atlas: breast imaging reporting and data system. American College of Radiology, Reston, VA, 2013; 2013."},{"key":"3247_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"3247_CR33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","volume":"95","author":"AN Freedman","year":"2003","unstructured":"Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst. 2003;95:526\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"3247_CR34","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","volume":"31","author":"K Visvanathan","year":"2013","unstructured":"Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:2942\u201362.","journal-title":"J Clin Oncol"},{"key":"3247_CR35","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/jpm11090916","volume":"11","author":"N Pashayan","year":"2021","unstructured":"Pashayan N, Antoniou AC, Lee A, Wolfson M, Chiquette J, Eloy L, et al. Should age-dependent absolute risk thresholds be used for risk stratification in risk-stratified breast cancer screening?. J Pers Med. 2021;11:916.","journal-title":"J Pers Med"},{"key":"3247_CR36","doi-asserted-by":"crossref","unstructured":"Lakeman IMM, Rodr\u00edguez-Girondo M, Lee A. Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort. Genet Med. 2020; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1098360021007759","DOI":"10.1038\/s41436-020-0884-4"},{"key":"3247_CR37","doi-asserted-by":"crossref","unstructured":"Yang X, Eriksson M, Czene K, Lee A, Leslie G Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. J Med. 2022; Available from: https:\/\/jmg.bmj.com\/content\/59\/12\/1196.abstract","DOI":"10.1136\/jmg-2022-108806"},{"key":"3247_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01399-7","volume":"23","author":"P Pal Choudhury","year":"2021","unstructured":"Pal Choudhury P, Brook MN, Hurson AN, Lee A, Mulder CV, Coulson P, et al. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry. Breast Cancer Res. 2021;23:22.","journal-title":"Breast Cancer Res"},{"key":"3247_CR39","doi-asserted-by":"publisher","unstructured":"Petitjean C, Wilcox N, Ficorella L, Dennis J, Tyrer J, Lush M, et al. Evaluating the performance of the BOADICEA model in predicting 10-year breast cancer risks in UK Biobank. J Natl Cancer Inst. 2024; Available from: https:\/\/doi.org\/10.1093\/jnci\/djae335","DOI":"10.1093\/jnci\/djae335"},{"key":"3247_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.5603\/GP.2016.0062","volume":"87","author":"B Radecka","year":"2016","unstructured":"Radecka B, Litwiniuk M. Breast cancer in young women. Ginekol Pol. 2016;87:659\u201363.","journal-title":"Ginekol Pol"},{"key":"3247_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","volume":"69","author":"Z Anastasiadi","year":"2017","unstructured":"Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313\u20137.","journal-title":"Updates Surg"},{"key":"3247_CR42","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.amjsurg.2009.06.010","volume":"198","author":"S Samphao","year":"2009","unstructured":"Samphao S, Wheeler AJ, Rafferty E, Michaelson JS, Specht MC, Gadd MA, et al. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009;198:538\u201343.","journal-title":"Am J Surg"},{"key":"3247_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JCO.2010.33.0068","volume":"30","author":"PJ Goodwin","year":"2012","unstructured":"Goodwin PJ, Phillips K-A, West DW, Ennis M, Hopper JL, John EM, et al. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. J Clin Oncol. 2012;30:19\u201326.","journal-title":"J Clin Oncol"},{"key":"3247_CR44","doi-asserted-by":"crossref","unstructured":"Collin CB, Gebhardt T, Golebiewski M, Karaderi T, Hillemanns M, Khan FM, et al. Computational Models for Clinical Applications in Personalized Medicine-Guidelines and Recommendations for Data Integration and Model Validation. Journal of Personalized Medicine. 2022;12:166.","DOI":"10.3390\/jpm12020166"},{"key":"3247_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/eurpub\/ckz161","volume":"29","author":"A Odone","year":"2019","unstructured":"Odone A, Buttigieg S, Ricciardi W, Azzopardi-Muscat N, Staines A. Public health digitalization in Europe: EUPHA vision, action and role in digital public health. Eur J Public Health. 2019;29:28\u201335.","journal-title":"Eur J Public Health"},{"key":"3247_CR46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","volume":"30","author":"T Carver","year":"2021","unstructured":"Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, et al. CanRisk Tool\u2014A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants. Cancer Epidemiol Biomark Prev. 2021;30:469\u201373.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3247_CR47","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/CLEP.S314959","volume":"13","author":"K Laugesen","year":"2021","unstructured":"Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, et al. Nordic health registry-based research: A review of health care systems and key registries. Clin Epidemiol. 2021;13:533\u201354.","journal-title":"Clin Epidemiol"},{"key":"3247_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/tme.12478","volume":"29","author":"AS Rigas","year":"2019","unstructured":"Rigas AS, Skytthe A, Erikstrup C, Rostgaard K, Petersen MS, Hjalgrim H, et al. The healthy donor effect impacts self-reported physical and mental health - results from the Danish Blood Donor Study (DBDS). Transfus Med. 2019;29:65\u20139.","journal-title":"Transfus Med"},{"key":"3247_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01667-8","volume":"25","author":"M Illipse","year":"2023","unstructured":"Illipse M, Czene K, Hall P, Humphreys K. Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach. Breast Cancer Res. 2023;25:64.","journal-title":"Breast Cancer Res"},{"key":"3247_CR50","unstructured":"Bojesen SE, Copenhagen University Hospital; University of Copenhagen. Population-based Randomized Study Of a Novel breast cancer risk ALgorithm and stratified screening (PRSONAL). ClinicalTrials.gov; 2023 [cited 2025 Aug 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06060938"},{"key":"3247_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09484-6","volume":"22","author":"A Roux","year":"2022","unstructured":"Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the \u201cMy Personal Breast Screening\u201d (MyPeBS) randomised clinical trial. BMC Cancer. 2022;22:507.","journal-title":"BMC Cancer"},{"key":"3247_CR52","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10549-021-06346-w","volume":"189","author":"L Esserman","year":"2021","unstructured":"Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, et al. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Res Treat. 2021;189:593\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"3247_CR53","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3390\/cancers16112116","volume":"16","author":"MJ Walker","year":"2024","unstructured":"Walker MJ, Blackmore KM, Chang A, Lambert-C\u00f4t\u00e9 L, Turgeon A, Antoniou AC, et al. Implementing multifactorial risk assessment with polygenic risk scores for personalized breast cancer screening in the population setting: Challenges and opportunities. Cancers. 2024;16:2116.","journal-title":"Cancers"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03247-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:22:11Z","timestamp":1768922531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03247-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,31]]}},"alternative-id":["3247"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03247-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ACA and LF are listed as creators of the BOADICEA model, which has been licensed from Cambridge Enterprise (University of Cambridge) for commercial purposes. SB has ownerships in Intomics A\/S, Hoba Therapeutics Aps, Novo Nordisk A\/S, Lundbeck A\/S, ALK abello A\/S, Eli Lilly and Co and managing board memberships in Proscion A\/S and Intomics A\/S. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors consented to publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All DBDS participants gave informed consent. All methods were performed in accordance with the relevant guidelines and regulations. This study was approved by the National Committee on Health Research Ethics (M-20090237\/1-10-72-95-13, NVK-1700407 and SJ-740) and the data protection in the Capital Region of Denmark (P-2019-99).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}